Indiana University - Kelley School of Business

Purdue University

Pharmaceutical and Biotech Executive

Indianapolis, Indiana, United States

Toralgen develops novel pharmaceuticals using a breakthrough nanoparticle drug delivery platform.  The company focuses on development of treatments for diabetes and autoimmune diseases.

Toralgen

Chief Operating Officer

Professor of Business Analytics for Masters in Management program and Market Research for The Lacy School of Business

Butler University - Lacy School of Business

Adjunct Professor

Escalate Insights Partners works with Biotech and Life Science companies to build Insights and Analytics capabilities by customizing solutions for improvement and working across the organization to implement changes.

Escalate Insights Partners

Partner

Worked with entrepreneurs on business plan, entity formation, ideation, market analysis and business model development.

Purdue Research Foundation

Entrepreneur In Residence

- Reduced annual spending by 35% while enhancing support of key business priorities through a multi-year transformation of global market research that leveraged new methods and capabilities.
- Enabled LillyUSA senior leadership to make better investment decisions by building a Business Integration Analytics team which partnered with internal Statistics team to build marketing mix and propensity models.
- Led a cross-functional change initiative to become a more customer-centric organization.  Resulted in a 12 point improvement in LillyUSA’s Net Promoter score and increased sales.

Eli Lilly and Company

Sr Director, Global Insights and Analytics

- Played key role in rejuvenating the Cymbalta brand after joining the team in 2006 when sales were flat. Identified and implemented a variety of growth opportunities that grew revenues from $1 Billion to $5 Billion.  Cymbalta was named “Brand of the Year” in 2010

Global Market Research and Analytics Director, Neuroscience Products

- Created launch strategy for 3 new products with combined peak sales of over $6 billion. One of these products had the most successful launch among neuroscience drugs in the industry (as measured by year 1 prescription volume). Developed launch plans, including budget, training, customer targeting, salesforce analytics, customer programming, promotional materials and sampling strategy.
- Enabled significantly better performance on customer and productivity objectives by leading a restructuring of LillyUSA's three primary care sales forces and promotional activities.
- Named 2001 Coaching Champion for the Northeast.

Business Unit Operations Director & District Sales Manager

- Assessed and pursued business development opportunities for the U.S. market. U.S. lead on deal team for the Actos® co-promotion agreement ($19 billion in lifetime sales) and the Cialis® co-promotion ($2 billion in annual sales). Lead negotiator in obtaining the PMDD patent for Prozac
- Led U.S. pre-launch marketing planning for Lilly’s pipeline of 16 products across all therapeutic areas.
- Managed LillyUSA’s annual strategic planning exercise, leading senior management through a portfolio management process.

Manager, New Product Planning and Business Development

- Reduced costs 25% by combining 3 packaging areas and functional support groups into a single, integrated flow.
- Reestablished a management structure, financial and production metrics and business processes.

Dave Moore